INTRODUCTION
Multicellular organisms have evolved in complex environments charged with diverse microbial ecosystems. This coevolution has led to the development of symbiotic relationships between microbes and more advanced organisms tightly regulated by the latter. The host has developed antimicrobial (for instance through the promotion of tightly regulated barrier functions), but also promicrobial strategies (through secretion of nourishing substances, such as mucus). Host immunity itself is not only closely associated with host defense, but also with microbial symbiosis. Therefore, the immune system may exert antimicrobial and promicrobial pressures, simultaneously. Symbionts induce both innate and adaptive host immunity, which affects immunity not only to symbionts but also toward pathogens. Across species acquisition of immune complexity (e.g. acquisition of adaptive immunity) is positively associated with host-embedded microbiota diversity, suggesting that evolved immunity allows the containment of highly diverse microbial ecosystems, thus fully exploiting their metabolic potential [1] . Symbionts also protect their host from pathogens by competition for energy sources and by secreting antimicrobial substances.
It has been repeatedly demonstrated that environmental factors strongly influence microbiota composition. For example, change of diet [2] , life style [3] , and migration [4, 5] have strong impact on gut microbiota composition. However, coevolution of host and its microbiota advocate for a host genetic component regulating microbiota composition both cross and intraspecies. It is generally difficult to segregate environmental and genetic effects on biological traits. The best method to differentiate between environmental and genetic effects in humans is to study monozygotic and dizygotic twin pairs, which when brought up together can be considered to encounter approximately the same environmental factors. Indeed, the first study [6] to describe variation in human host genetics as a determinant for gut microbiota composition was conducted in a small twin cohort, suggesting that monozygotic twins have more similar gut microbiota composition than dizygotic twins. This observation was later tested in larger twin cohorts with state-of-the-art next generation sequencing analysis confirming that monozygotic twins have more similar gut microbiota composition compared with dizygotic twins [7,8 & ]. At the population level, a range of chronic diseases, such as inflammatory bowel disease (IBD) [9] , diabetes [10, 11] , and allergy [12 & ], with well known genetic cause have recently been demonstrated to have dysbiotic gut microbiomes. If the dysbiosis observed in these pathologies are dependent or independent of host genetics remains unresolved.
HERITABILITY OF GUT MICROBIOTA IN ANIMAL MODELS
Benson et al. [13] were the first to identify quantitative trait loci (QTL) in an intercross outbred mouse line associated with major gut microbial taxa. A CARD9 homozygous mutation resulting in a premature termination codon was previously associated with susceptibility to fungal infection, likely caused by an impaired innate signaling from the antifungal pattern-recognition receptor dectin-1 [27] , which is also crucial for sIgA-bound antigen uptake by M cells and downstream antigen presentation [28] . Moreover, CARD9 is associated with IBD, likely as a result of reduced abundance of bacteria with capacity to metabolize tryptophan into aryl hydrocarbon receptor (AHR) agonists, such as Lactobacillus [Firmicutes;Bacilli] [23 && ]. AHR-activity stimulates local intestinal IL-22 secretion, which has important influence on barrier function and bacterial defense mechanisms such as defensin secretion. Indeed, treatment with Lactobacillus strains rescues colitogenic mice. Moreover, CARD9 knock-out mice show significantly reduced abundance of Adlercreutzia [Actinobacteria;Actinobacteria], which is a member of the coriobacteriacceae family [23 && ]. As mentioned above, Coriobacteriacceae was previously associated with a QTL localized on mouse chromosome 10, which includes genes encoding IL-22 [13] . Since only CARD9 is located on mouse chromosome 2 (but none of the QTLs identified in the previous study), it is possible that the association between Adlercreutzia [Actinobacteria; Actinobacteria] and CARD9 is an indirect effect
KEY POINTS
Host genes involved in metabolism and host defense are associated with gut microbiota composition.
Host immune features are associated with gut microbiota composition.
A subset of gut microbes are both affected by host gene polymorphisms and host immune features, suggesting a sequential mechanistic link between host genetics, host immunity, and gut microbiota composition.
Genetic evolution is associated with regulation of gut microbial symbiosis via regulatory T cells and sIgA.
Host genetics should be considered in the context of therapeutic approaches targeting the gut microbiota. of the influence of CARD9 on AHR-mediated IL-22 secretion. Brain and muscle AHR nuclear translocator-like protein-1 (Bmal1) is a transcription factor involved in the regulation of the circadian rhythm, which itself is transcriptionally regulated by a retinoic acidrelated orphan receptor response element-binding site (RORE) located in the promotor of Bmal1. One of the ROR transcription factors binding RORE is RORg, which is tightly linked with regulating Th17 cell differentiation and maintaining a balanced equilibrium between inducible regulatory T cells (iTreg) and Th17 cells. It was recently demonstrated that the equilibrium between gut microbes from the phyla Bacteroidetes and Firmicutes is associated with the circadian cycle with Bacteroidetes peaking several hours into the dark phase and Firmicutes peaking at the beginning of the light phase [24 & ]. Bmal1 knock-out mice lose this circadian change of their gut microbiota. Finally, two haplotypes of Bmal1 in humans have been shown to be associated with type 2 diabetes [29] , a disorder associated with gut microbiota dysbiosis [10, 11] .
The intestinal barrier physically separates gut microbiota from the host. As such it serves as the first line of defense. Second line of defense includes innate immune functions, such as antimicrobial peptides (e.g. defensins), which are secreted by cells in the barrier as a result of host sensing of microbes, which threaten to translocate across the barrier and thus invade the host. Evolutionarily, these defense mechanisms have developed very early. A number of genes regulating these defensive pathways show polymorphisms even in less complex organisms, such as Arabidopsis [30 && ] and the fruit fly [25 & ]. Indeed, polymorphisms of fruit fly genes, such as polychaetoid ( pyd) and defensin (def), have been associated with gut microbiota dysbiosis manifested as variation in the abundance of Acetobacter tropicalis [Proteobacteria;Alphaproteobacteria] ( Table 1) . Of note, the pyd gene is homologous to human genes involved in the regulation of tight junctions, which control the permeability of the intestinal barrier.
Animal studies addressing the association between host gene polymorphisms and gut microbiota highlight the importance of host defense in the regulation of gut microbiota homeostasis. Animal studies are particularly well adapted for this type of analysis, because confounding factors, such as diet and environment may be harmonized, and because the effect of identified genes may be tested in knock-out models. Of note, animal models may encompass less host genetic diversity. Contrarily, confounding factors in human studies add a significant amount of variance to the microbiota composition to be associated with genetic variation. Classic genome-wide association studies (GWAS) with a limited amount of phenotypic traits compensate for such variation by increased cohort size. However, when the phenotypic traits are the abundance of hundreds of individual microbes, multiple comparisons seriously affect statistical power, thus requiring extremely large cohorts. In the next section we will discuss the associations between human genes and microbial abundances. In light of the statistical power of these analyses it is likely that we are still only observing the top of the iceberg. Slightly weaker but nevertheless meaningful disease-specific associations may be obtained from larger or targeted future studies.
HUMAN HERITABILITY OF MICROBIOTA
The first human GWAS using microbiota composition from various body sites as associative phenotypic trait included 93 individuals from the human microbiome project [19 && ]. To gain statistical power they performed a principal component analysis of the microbiota composition data stratified by body site and utilized the top-5 principal components of these analyses as phenotypic traits. A number of host defense-related pathways were identified using this approach, including leptin, JAK/Stat, chemokine, and pattern-recognition receptor signaling. These were all associated with microbiota composition of nose, throat, and skin. Similarly, two single nucleotide polymorphisms (SNPs) in human leukocyte antigen -DRA and Toll-like receptor 1 were associated with the abundance of throat-derived Selenomonas and tongue dorsum-derived Lautropia, respectively (Table 1) . Gut-derived Bifidobacterium was associated with a SNP in the lactase (LCT) gene, which encodes lactase enzyme pivotal for the cleavage of diary-derived lactose. Of note, the LCT polymorphism is associated with lactose tolerance. Moreover, individuals with a functional LCT gene had lower levels of Bifidobacterium, likely because the host degrade lactose, thereby depriving Bifidobacterium for an important energy source. Importantly, the link between LCT and Bifidobacterium has also been observed in the Hutterites populations although without reaching statistical significance [18 & ] and confirmed in the largest study [20 && ] to date, including 2139 individuals among which 890 monozygotic and dizygotic twin pairs. The latter study, furthermore, identified GNA12 and CD36 genes, which are involved in barrier defense and innate immunity, respectively. GNA12 and CD36 polymorphisms are associated with gut abundances of SMB53 [Firmicutes;Clostridia] and Blautia [Firmicutes;Clostridia], respectively. In an independent study, Si et al. [17 & ] identified a gene, filaggrin (FLG), related to epidermal barrier function, which is associated with Corynebacterium jeikeium [Actinobacteria;Actionbacteria] abundance. Finally, haplotypes of the 8.1 ancestral haplotype (AH8.1) gene associated with a large number of human autoimmune diseases as well as a polymorphism of the HLA-DQ2 gene associated with strong genetic risk of coeliac disease were associated with gut microbial composition ( Table 1) .
Beyond host defense-related genes, a number of genes involved in host metabolism were discovered. Two genes implicated in blood lipid traits (apolipoprotein A-V and Rab GTPase-activating protein 1) were associated with the gut microbiota abundance of Bifidobacterium 
CROSS TALK BETWEEN GUT MICROBIOTA AND CELLULAR IMMUNITY
Microbes play important roles for the development and maturation of host immunity. Indeed, germfree mice display a severely impaired immune system affecting the development of Peyer's patches and germinal centers of the small intestine. In the absence of specialized sites for T and B-cell differentiation and maturation, the germ-free mice display reduced levels of CD4 þ and CD8 þ T cells, including iTregs. Th17 cells show a dichotomy with reduced levels in the small intestine and increased levels in the colon. Moreover, germ-free mice have drastically reduced levels of sIgA [31] .
More specifically, Th17 cells may be induced by mucolytic members of the gut microbiota, such as segmented filamentous bacteria (SFB), Citrobacter rodentium and Escherichia coli, but also by a consortium of 20 bacteria displaying mucolytic characteristic isolated from an ulcerative colitis patient [32 && ]. Equally, the induction and maturation of intestinal iTreg cells is affected by the presence of a large number of species from the Clostridium genus as well as species of the Lactobacillus genus [32 && ,33]. Probiotic treatment of mice with these strains shows an effect on iTreg development and maturation. Moreover, polysaccharide A released by several species from the Bacteroides genus is able to induce IL-10 secretion by dendritic cells, which may drive iTreg differentiation [34, 35] .
CROSS TALK BETWEEN GUT MICROBIOTA AND HUMORAL IMMUNITY (SECRETORY IgA)
Although microbes colonize all accessible body habitats, including skin, oral, nose, vagina, and even the lung, almost all our knowledge with regard to the impact of natural microbial colonization on host immunity is restrained to the densest microbial community known to man, the gut microbiota. In recent years the development of flow cytometric analysis of sIgA-bound gut microbiota [36] and associated sorting procedures [37] have allowed an accurate evaluation of gut microbiota targeted by sIgA [9,38 & ]. All these studies describe a heterogeneous sIgA immune response to gut microbiota with large variation between healthy individuals. However, all studies agree that the main targets of sIgA are found among the three phyla, Firmicutes, Proteobacteria, and Actinobacteria, which are also the more hereditable phyla. Previously reported sIgA/microbial interactions identified in literature are summarized in Fig. 1 , highlighting Bifidobacterium, Lactobacillus, Clostridium, SFB, Escherichia, and Akkermansia as prominent sIgA targets. Of note, Lactobacillus, Clostridium, SFB, and Escherichia all impact cellular immunity, whereas Bifidobacterium, Lactobacillus, Clostridium, and Akkermansia have been associated with host gene polymorphisms (Fig. 1) . Bifidobacterium are associated with host genes relevant for both host defense and nondefense pathways; Lactobacillus and Clostridium are uniquely associated with defense genes and Akkermansia is uniquely linked with nondefense genes. It is intriguing to notice that taxa (Lactobacillus and Clostridium) associated with regulatory T-cell biology are The plot illustrates associations between microbiota members and host features (genetics and immunity). Gut microbiota members are stratified according to phylum (inner circle labels) and class (outer circle labels). Of note, phyla B and D corresponds to Bacteroidetes and Deferribacteres, respectively. Each member is taxonomically identified at family or genus level (radial outer circle labels). Host genes are grouped according to their reported association with autoimmunity, host defense (defense) or other functions (nondefense). Host immune features comprise humoral (sIgA) and cellular (Th17 and iTreg) immunity. Associations between microbes and host genes, immune cells and/or sIgA are indicated with colored ribbons (green, red, and blue, respectively). Only microbes with known association with either host genes ( the only two taxa also associated with both sIgA and host defense gene polymorphisms (Fig. 1) . Contrarily, Th17 cells are associated with pathobiont taxa (SFB, E. coli, and Citrobacter) bound by sIgA but nonassociated with host genetics. It is, therefore, tempting to speculate that host fitness through genetic evolution has prioritized regulating the symbiosis between host and microbiota above eliminating external danger through proinflammatory responses.
Interestingly, no bacteria from the Bacteriodetes phylum (approximately 50% of the human gut microbiome) are found to interact with sIgA under nonpathological conditions nor do they associate with host gene polymorphisms. It is possible that extended evolutionary adaptation between host and Bacteroidetes-derived bacteria make associated host genes particularly conserved and thus undetectable in GWAS. Palm et al. observed that Bacteroidetesderived bacteria from the Prevotellacaceae family were bound by sIgA in mice suffering from colitis, suggesting that deleterious associations between host genetics and immunity may be observed in patients' cohort studies [9] . They moreover demonstrated that sIgA-bound gut microbiota are colitogenic and evoke disorder in healthy mice upon transplantation. Finally, several immune genes are associated with microbe abundances merely in the throat and tongue dorsal rather than in the gut [19 && ]. It is, therefore, likely that future studies focusing on these body sites may reveal many more interactions between host immunity and microbiota.
CONCLUSION
In recent years, fecal microbiota transplantation (FMT) has become a recognized therapeutic solution for Clostridium difficile infections and a promising therapeutic solution for chronic diseases associated with gut microbial dysbiosis, such as IBD, type 2 diabetes, rheumatoid arthritis, multiple sclerosis, and asthma [42, 43] . Knowing how host genetic makeup impacts gut microbiota composition will be of major importance to understand if FMTs may have long-term beneficial impact on chronic diseases or if host genetics will enforce a dysbiotic equilibrium. Indeed, a recent kinetic study [44] post-FMT has shown that FMTs are unstable. In future, such instability should be ascribed not only to divergent life styles between donor and recipient but also genetic differences. Depending on the extent of the impact of host genetics on gut microbiota composition, FMTs in the context of chronic disease may possibly need a donor/recipient genetic match for at least a set of SNPs or better yet therapeutic compensation for lost or gained functionalities according to patient genotype. So far no GWAS has been conducted on cohorts of individuals suffering from allergic diseases using gut microbiota composition as phenotypic trait. However, GWAS studies of allergic diseases have previously identified numerous polymorphisms in host genes associated with host defense in line with host genes identified to be associated with gut microbiota composition [45] . Indeed, HLA-DQ and FLG genes, which are associated with gut microbiota composition (Table 1) , have also been associated with allergic asthma, atopic dermatitis (eczema), and seasonal allergic rhinitis. Moreover, allergic disease imprints a biased gut microbiota composition [12 & ]. It is, therefore, likely that future studies will identify crucial links between gut microbiota composition and host genetics in allergic diseases. This could shed light on the underlying causes of disease and may guide the development of the pathway-specific therapeutics necessary to deal with the growing incidence of allergies. GWAS study of 110 inbred mouse lines associated with gut microbiota composition. The study identifies several host genes involved in host immunity and metabolism. The study is an important extension to the QTL study by Benson et al. [13] . 22.
